Covidien (COV) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Research and development expenses: 133M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development expenses: 133M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q2 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $3.01 billion versus the consensus estimate of $3.01 billion.
For earnings history and earnings-related data on Covidien (COV) click here.
For earnings history and earnings-related data on Covidien (COV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Ross Stores raises 2026 outlook after strong second-quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
